Credit Suisse Initiates Coverage on Xencor (XNCR)
Equities research analysts at Credit Suisse assumed coverage on shares of Xencor (NASDAQ:XNCR) in a research note issued to investors on Friday, TheFlyOnTheWall.com reports. The firm set an “outperform” rating on the stock.
Several other analysts have also recently commented on the stock. Analysts at Wedbush initiated coverage on shares of Xencor in a research note to investors on Tuesday. They set an “outperform” rating on the stock. Analysts at Leerink Swann initiated coverage on shares of Xencor in a research note to investors on Monday. They set an “outperform” rating and a $11.00 price target on the stock.
Shares of Xencor (NASDAQ:XNCR) opened at 8.88 on Friday. Xencor has a 1-year low of $7.70 and a 1-year high of $10.90. The stock has a 50-day moving average of $8.70 and a 200-day moving average of $8.70. The company’s market cap is $261.3 million.
Xencor, Inc (NASDAQ:XNCR) is a clinical-stage biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.